A comprehensive new analysis has found that the antidepressant escitalopram is the most effective at preventing relapse in patients with depression. The study, published in The Lancet Psychiatry, examined data from nearly 10,000 individuals who were prescribed various medications for up to a year.
Key Findings
Escitalopram outperformed other antidepressants in keeping patients free of depressive symptoms. Following closely were agomelatine and duloxetine, while fluoxetine (commonly known as Prozac) ranked slightly lower. The research, which reviewed previous studies comparing more than a dozen common antidepressants, revealed modest differences between the drugs.
Experts caution that these results do not suggest that all patients should switch to escitalopram or that other antidepressants are ineffective. Each medication has its own benefits and risks, and individual responses vary.
Clinical Implications
Depression affects approximately one in six people in the UK, and while many recover with treatment, relapse is common. Current guidelines recommend that patients continue antidepressants for at least six months after symptoms improve, then gradually reduce the dose.
Professor Eric Ruhé from Radboud University in the Netherlands, one of the researchers, emphasized that the choice of medication should be personalized. "Our study can help inform the decisions that prescribers and patients make together: if you start an antidepressant, choose one that not only helps you to get well, but also keeps you well," he said.
Dr Sameer Jauhar from Imperial College London added, "While the research provides useful information, it cannot tell us which antidepressant will work best for an individual patient. I would not interpret these findings as a reason for someone who is responding well to their current antidepressant to change treatment."
Balancing Benefits and Side Effects
Like all medications, escitalopram can cause side effects such as sleep problems, constipation, and weight gain, though not everyone experiences them. The NHS notes that if escitalopram or similar SSRIs are ineffective or unsuitable, doctors may prescribe a different type of antidepressant, such as an SNRI.
Professor Allan Young from the Royal College of Psychiatrists commented, "While some medicines appear to have a small advantage over others for longer-term outcomes, the differences are modest and are unlikely to outweigh individual factors such as side effects, previous response, and patient preference when deciding on treatment."
Mind, a mental health charity, stresses the importance of accessible information about the benefits and side effects of antidepressants, as well as alternative support like talking therapies and mindfulness. "It's common for people to need to try more than one medication before they find the right treatment that works for them. And what works may change over time," the charity said.
As research continues, longer studies are needed to further understand the long-term effectiveness of different antidepressants. In the meantime, patients are encouraged to discuss treatment options with their healthcare providers to make informed decisions.
